FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window
With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from June 30, 2021 till 48 hours of declaration of financial results for the quarter ending on June 30, 2021. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD1/27/2019 dated February 8, 2019, as amended, please find enclosed the Annual Secretarial Compliance Report of the Company for the Financial Year 2020-21. Fortis Healthcare Ltd - 532843 - Update - Approval Of Re-Classification Of Promoters Of Fortis Malar Hospitals Limited, A Step- Down Subsidiary Company.
This is to inform you that Fortis Malar Hospitals Limited ('FMHL'), a step-down subsidiary Company has received an approval from BSE Limited vide its letter no. LIST/COMP/MI/002/2021-22 dated June 24, 2021 received through e-mail on June 25, 2021, for re-classification of its promoters under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details of the outgoing promoters of FMHL are mentioned below: - (i) Malvinder Mohan Singh (ii) Shivi Holdings (P) Limited (iii) RHC Finance Private Limited (iv) Todays Holdings Private limited (v) Oscar Investments Limited (vi) Malav Holdings Private Limited (vii) RHC Holdings Private Limited (viii) Fortis Healthcare Holdings Private Limited The remaining promoter of FMHL is Fortis Hospitals Limited. A detailed disclosure as made by FMHL in this regard along with approval letter of BSE is enclosed. This is for your information and records. FORTIS HEALTHCARE LTD. - 532843 - Regulation 23 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015- Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021.
Dear Sir(s), In compliance of Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find attached disclosure of Related Party Transactions for the half year ended March 31, 2021. This is for your information and records please.
Sputnik V COVID-19 vaccine to be available at 2 Fortis Hospitals from June 19
The two hospitals that are participating in the pilot roll-out of Sputnik V are Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Mohali
HDFC Securities sees 15% upside in Fortis Healthcare despite cap on vaccination charge, here's why
The brokerage firm has a buy on the stock on dips around Rs 199-200 with a target price of Rs 271, an upside of 15 percent from the current level. Private hospitals divided on Rs 150 cap on COVID-19 vaccine administration charges
Corporate hospital chains such as Apollo, Max Healthcare, Fortis Healthcare, Narayana Health and Manipal Hospitals have shown huge interest in offering COVID-19 vaccination.
Fortis Healthcare reports Rs 62 cr net profit in Q4 of FY21
Consolidated revenue from operations of the company stood at Rs 1,252.44 crore for the quarter under consideration. It was Rs 1,112.92 crore for the same period a year ago Fortis Healthcare Ltd - 532843 - Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. Fortis Healthcare Ltd - 532843 - Outcome Of The Board Meeting
Dear Sir(s), Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today inter-alia, considered and approved the Audited Standalone and Consolidated Financial results of the Company for the quarter and financial year ended March 31, 2021. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with modified opinion along with Statement of impact of Modified Opinion thereon; Accordingly, please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 12 Noon and concluded at 18:10 Hours IST. T